William Anderson

Dr. William Anderson


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2021 in Histopathology
Verified
Journal Article
Closed access
PDF file
WAWilliam Anderson
William Anderson
LDLeona A Doyle
Leona A Doyle

1 March 2019 in Seminars in Diagnostic Pathology
Verified
Journal Article
Closed access
WAWilliam Anderson
William Anderson
VJVickie Jo
Vickie Jo

1 March 2023 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
WAWilliam Anderson
William Anderson
FDFei Dong
Fei Dong
CFChristopher D.M. Fletcher
Christopher D.M. Fletcher
MHMichelle S. Hirsch
Michelle S. Hirsch
MNMarisa R. Nucci
Marisa R. Nucci
Perivascular epithelioid cell tumors (PEComas) are a distinctive group of mesenchymal neoplasms that demonstrate features of smooth muscle and melanocytic differentiation. Here, we present the clinicopathologic, immunohistochemical, and molecular features of 15 uterine sarcomas diagnosed as malignant PEComa. The median patient age was 56 years (range: 27 to 86 y). The median tumor size was 8.0 cm (range: 5.0 to 14.0 cm). All tumors were classified as malignant based on the presence of mitoses (15/15; 100%), necrosis (15/15; 100%), lymphovascular invasion (8/15; 53%), and high nuclear grade (13/15; 87%). Molecular analysis revealed the mammalian target of rapamycin pathway gene mutations in 7 cases (47%), including mutually exclusive variants in TSC1 (27%) and TSC2 (20%). Recurrent alterations were also identified in TP53 (53%), RB1 (30%), ATRX (33%), and BRCA2 (13%). Tumors with inactivating ATRX mutations all demonstrated loss of ATRX expression by immunohistochemistry. Loss of expression was also observed in 2 tumors without demonstrable ATRX alterations. Clinical follow-up was available for 14 patients (range: 5 to 92 mo; median: 15 mo). Five patients developed local recurrence and 9 developed metastases; 2 patients died of their disease. Our series expands the spectrum of molecular events in tumors diagnosed as malignant PEComa and further highlights the important role of targeted sequencing in tumors with focal melanocytic marker expression.

15 November 2021 in Histopathology
Verified
Journal Article
Closed access
PDF file
WAWilliam Anderson
William Anderson
JGJennifer B. Gordetsky
Jennifer B. Gordetsky
MIMuhammad T. Idrees
Muhammad T. Idrees
KAKhaleel I Al‐Obaidy
Khaleel I Al‐Obaidy
CKChia‐Sui Kao
Chia‐Sui Kao
AAAndres Martin Acosta
Andres Martin Acosta

1 November 2018 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
PDF file
WAWilliam Anderson
William Anderson
JHJason L Hornick
Jason L Hornick

10 May 2022 in Histopathology
Verified
Journal Article
Closed access
WAWilliam Anderson
William Anderson
LSLynette M Sholl
Lynette M Sholl
CFChristopher D M Fletcher
Christopher D M Fletcher
SSStephanie Schulte
Stephanie Schulte
LWLi Juan Wang
Li Juan Wang
MHMichelle Hirsch Hirsch
Michelle Hirsch Hirsch